These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 15454255)

  • 21. Pathological effects of glyoxalase I inhibition in SH-SY5Y neuroblastoma cells.
    Kuhla B; Lüth HJ; Haferburg D; Weick M; Reichenbach A; Arendt T; Münch G
    J Neurosci Res; 2006 Jun; 83(8):1591-600. PubMed ID: 16555297
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of glyoxalase I by various clinically used anticancer drugs.
    Kraus JL; Pernice P; Ponce C
    Res Commun Chem Pathol Pharmacol; 1988 Mar; 59(3):419-22. PubMed ID: 3363227
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduced elimination of Methotrexate in an adult with trisomy 21 and acute lymphoblastic leukaemia.
    Thachil J
    Leuk Res; 2007 Oct; 31(10):1452-3. PubMed ID: 17178159
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparison of long-term neurocognitive outcomes in young children with acute lymphoblastic leukemia treated with cranial radiation or high-dose or very high-dose intravenous methotrexate.
    Spiegler BJ; Kennedy K; Maze R; Greenberg ML; Weitzman S; Hitzler JK; Nathan PC
    J Clin Oncol; 2006 Aug; 24(24):3858-64. PubMed ID: 16921038
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacodynamic properties of methotrexate and Aminotrexate during weekly therapy.
    Cole PD; Zebala JA; Alcaraz MJ; Smith AK; Tan J; Kamen BA
    Cancer Chemother Pharmacol; 2006 Jun; 57(6):826-34. PubMed ID: 16170572
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Population pharmacokinetic study of methotrexate in patients with lymphoid malignancy.
    Faltaos DW; Hulot JS; Urien S; Morel V; Kaloshi G; Fernandez C; Xuan kH; Leblond V; Lechat P
    Cancer Chemother Pharmacol; 2006 Nov; 58(5):626-33. PubMed ID: 16528531
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interference of 7-hydroxymethotrexate with the determination of methotrexate in plasma samples from children with acute lymphoblastic leukemia employing routine clinical assays.
    Fotoohi K; Skärby T; Söderhäll S; Peterson C; Albertioni F
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Mar; 817(2):139-44. PubMed ID: 15686977
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methotrexate intracellular disposition in acute lymphoblastic leukemia: a mathematical model of gamma-glutamyl hydrolase activity.
    Panetta JC; Wall A; Pui CH; Relling MV; Evans WE
    Clin Cancer Res; 2002 Jul; 8(7):2423-9. PubMed ID: 12114448
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Late-onset delayed excretion of methotrexate.
    Pauley JL; Panetta JC; Schmidt J; Kornegay N; Relling MV; Pui CH
    Cancer Chemother Pharmacol; 2004 Aug; 54(2):146-52. PubMed ID: 15148625
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A case for the use of aminopterin in treatment of patients with leukemia based on metabolic studies of blasts in vitro.
    Smith A; Hum M; Winick NJ; Kamen BA
    Clin Cancer Res; 1996 Jan; 2(1):69-73. PubMed ID: 9816092
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gene expression profiling of leukemia T-cells resistant to methotrexate and 7-hydroxymethotrexate reveals alterations that preserve intracellular levels of folate and nucleotide biosynthesis.
    Fotoohi AK; Assaraf YG; Moshfegh A; Hashemi J; Jansen G; Peters GJ; Larsson C; Albertioni F
    Biochem Pharmacol; 2009 Apr; 77(8):1410-7. PubMed ID: 19426680
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Brief report: effect of intravenous methotrexate dose and infusion rate on neuropsychological function one year after diagnosis of acute lymphoblastic leukemia.
    Carey ME; Hockenberry MJ; Moore IM; Hutter JJ; Krull KR; Pasvogel A; Kaemingk KL
    J Pediatr Psychol; 2007 Mar; 32(2):189-93. PubMed ID: 16675716
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polyuria associated with high-dose methotrexate in two patients with acute lymphoblastic leukaemia.
    Lau KK; Weiss AR; Jones DP
    J Oncol Pharm Pract; 2005 Mar; 11(1):31-3. PubMed ID: 16460601
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DHFR and MSH3 co-amplification in childhood acute lymphoblastic leukaemia, in vitro and in vivo.
    Matheson EC; Hogarth LA; Case MC; Irving JA; Hall AG
    Carcinogenesis; 2007 Jun; 28(6):1341-6. PubMed ID: 17148505
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanism-based competitive inhibitors of glyoxalase I: intracellular delivery, in vitro antitumor activities, and stabilities in human serum and mouse serum.
    Kavarana MJ; Kovaleva EG; Creighton DJ; Wollman MB; Eiseman JL
    J Med Chem; 1999 Jan; 42(2):221-8. PubMed ID: 9925727
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-dose methotrexate and/or leucovorin rescue for the treatment of children with lymphoblastic malignancies: do we really know why, when and how?
    Sterba J; Valík D; Bajciová V; Kadlecová V; Gregorová V; Mendelová D
    Neoplasma; 2005; 52(6):456-63. PubMed ID: 16284689
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methotrexate-associated alterations of the folate and methyl-transfer pathway in the CSF of ALL patients with and without symptoms of neurotoxicity.
    Vezmar S; Schüsseler P; Becker A; Bode U; Jaehde U
    Pediatr Blood Cancer; 2009 Jan; 52(1):26-32. PubMed ID: 19006245
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacogenetics of methotrexate in acute lymphoblastic leukaemia: why still at the bench level?
    Kodidela S; Suresh Chandra P; Dubashi B
    Eur J Clin Pharmacol; 2014 Mar; 70(3):253-60. PubMed ID: 24370659
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A limited sampling strategy to estimate individual pharmacokinetic parameters of methotrexate in children with acute lymphoblastic leukemia.
    Plard C; Bressolle F; Fakhoury M; Zhang D; Yacouben K; Rieutord A; Jacqz-Aigrain E
    Cancer Chemother Pharmacol; 2007 Sep; 60(4):609-20. PubMed ID: 17195068
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Infants with acute lymphoblastic leukemia: no evidence for high methotrexate resistance.
    Ramakers-van Woerden NL; Pieters R; Rots MG; van Zantwijk CH; Noordhuis P; Beverloo HB; Peters GJ; van Wering ER; Camitta BM; Pui CH; Relling MV; Evans WE; Veerman AJ
    Leukemia; 2002 May; 16(5):949-51. PubMed ID: 11986959
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.